Is Owens & Minor (OMI) a Great Stock for Value Investors?

01:35pm, Friday, 25'th Mar 2022 Zacks Investment Research
Is Owens & Minor (OMI) a great pick from the value investor's perspective right now? Read on to know more.
Is Owens & Minor (OMI) a great pick from the value investor's perspective right now? Read on to know more.
Owens & Minor, Thermo Fisher Scientific, Medtronic and Becton, Dickinson and Co. have been included in this Analyst Blog.
MedTech stocks like Owens & Minor (OMI), Thermo Fisher (TMO) and Medtronic (MDT) are prudent investment choices given their long-term growth potential with recent M&A deals.
We think that Intuit stock, a company that specializes in financial and tax preparation software, currently is a better pick compared to medical devices maker Owens & Minor stock, a global healthcare
Healthcare technology company Owens & Minor Inc. OMI, +3.25% said Friday it has launched a private offering of $500 million of 8-year high-yield bonds. Proceeds will be used to fund the acquisition of

Cardiovascular Systems' (CSII) Low Procedure Volume Dents Sales

04:01pm, Monday, 14'th Mar 2022 Zacks Investment Research
Cardiovascular Systems (CSII) notes that recovery from the Delta variant has been suppressed by the emergence of the highly contagious Omicron variant.

Zimmer Biomet (ZBH) New WalkAI Model to Bolster Robotics Arm

02:41pm, Monday, 14'th Mar 2022 Zacks Investment Research
WalkAI adds powerful predictive analytic capabilities to ZBEdge, Zimmer Biomet's (ZBH) suite of integrated digital and robotic technologies.

Here's Why You Should Hold on to LabCorp (LH) Stock For Now

03:47pm, Friday, 11'th Mar 2022 Zacks Investment Research
Investors are optimistic about LabCorp's (LH) better-than-expected results and robust base business performance.

Allscripts (MDRX) Unveils Newly Rebranded App Expo Site

02:15pm, Thursday, 10'th Mar 2022 Zacks Investment Research
Allscripts' (MDRX) rebranded App Expo site to offer developers an opportunity to present their certified solutions online.

Here's Why You Should Retain Syneos Health (SYNH) For Now

02:13pm, Thursday, 10'th Mar 2022 Zacks Investment Research
Investors are optimistic about Syneos Health's (SYNH) better-than-expected earnings and robust segmental performance.
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor to Present at the Barclays Global Healthcare Conference Tuesday, March 15, 2022

Quest Diagnostics (DGX) Base Sales Recover Amid Price Woe

02:59pm, Wednesday, 09'th Mar 2022 Zacks Investment Research
Quest Diagnostics (DGX) raises 2022 guidance based on the continued rebound in base business and recent investments expected to accelerate growth.

Allscripts (MDRX) Inks Divestment Deal to Focus on Core Wing

02:15pm, Wednesday, 09'th Mar 2022 Zacks Investment Research
Constellation Software will purchase the net assets of Allscripts' (MDRX) Hospitals and Large Physician Practices business segment via its wholly-owned subsidiary.

Bio-Rad's (BIO) Product Launches Aid Growth, Global Arm Strong

04:21pm, Tuesday, 08'th Mar 2022 Zacks Investment Research
Bio-Rad's (BIO) Diagnostics business registers growth across all its product lines, driven by the recovery of routine testing.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE